Found 9 articles for: "race"
The Dermoepidermal Junction as the Initiation Point for Reversal of Dermatoporosis
April 2026 | Volume 25 | Issue 4 | Original Article | 377 | Copyright © April 2026
Background: Dermatoporosis (DP) or chronic cutaneous fragility syndrome has traditionally been linked to extracellular matrix (ECM) dehydration, reduced cellular turnover, epider...
Read MoreTransitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity
March 2026 | Volume 25 | Issue 3 | Original Article | 268 | Copyright © March 2026
Background: Skin thinning, known as dermatoporosis, is an expected consequence of aging that involves structural weaknesses, barrier deficiencies, and cellular senescence, posing...
Read MoreRacial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome
February 2026 | Volume 25 | Issue 2 | Original Article | 159 | Copyright © February 2026
Background: Racial disparities in clinical trial enrollment can limit the generalizability of therapeutic data, which is particularly damaging for conditions that disproportionat...
Read MoreTopical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants
January 2026 | Volume 25 | Issue 1 | Original Article | 67 | Copyright © January 2026
Background: Topical efinaconazole 10% solution has demonstrated efficacy and safety in two phase 3 trials of onychomycosis. As clinical data for onychomycosis treatments are limi...
Read MoreInsights Into Demographics, Comorbidities, and Risk Factors in Keloids and Hypertrophic Scars: A Retrospective Study
February 2025 | Volume 24 | Issue 2 | Features | 212 | Copyright © February 2025
Hypertrophic scars and keloids represent abnormal wound healing, manifesting as raised scars confined to or extending beyond the wound margin, respectively. Understanding the risk factors associated w...
Read MoreA Prospective, Multi-Center Study to Evaluate the Safety and Efficacy of a Vegan Nutraceutical to Improve Hair Growth and Quality in Females Following a Plant-Based Diet
August 2024 | Volume 23 | Issue 8 | Original Article | 661 | Copyright © August 2024
Hair thinning affects upwards of 50% of women by age 50, impacting their social-emotional wellbeing. It is a condition now thought to be driven by a multi-factorial etiology, including diet and n...
Read MoreWATCH VIDEO ABSTRACT: Dermatoporosis: Strategies for Rebuilding the Extracellular Matrix of the Skin
September 2023 | Volume 22 | Issue 9 | Original Article | 861 | Copyright © September 2023
Read MoreA Long-Term Study of the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Perimenopausal, Menopausal, and Postmenopausal Women
July 2022 | Volume 21 | Issue 7 | Original Article | 783 | Copyright © July 2022
The prevalence of female hair loss and hair thinning increases with advancing age and is most common among post-menopausal women. Recent statistics show that by age 60, an estimated 80% of women exper...
Read MoreAdding Combined Oral Contraceptives or Metformin to Laser Treatment in Polycystic Ovarian Syndrome Hirsute Patients
March 2021 | Volume 20 | Issue 3 | Original Article | 302 | Copyright © March 2021
Background: Hirsutism is estimated to affect 10% to 20% of females, provoking significant psychological damage and social embarrassment. Polycystic ovary syndrome is a major cause of ...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
